FIRST NEW YORK SECURITIES LLC /NY - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 90 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
FIRST NEW YORK SECURITIES LLC /NY ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$14,266,000
-28.2%
35,000
-34.1%
0.03%
+107.7%
Q3 2016$19,875,000
-94.3%
53,100
-72.2%
0.01%
-96.2%
Q1 2015$345,710,000
+367.4%
191,000
+525.0%
0.34%
+555.8%
Q3 2014$73,960,000–30,562–0.05%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2014.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders